drugset / Trial / NCT03040635
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Risdiplam (RO7034067) in Healthy Japanese Participants
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a randomized, placebo-controlled study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of single oral doses of Risdiplam in healthy Japanese participants.
Timeline
- Start
- 2017-03-22
- Primary completion
- 2017-10-02
- Completion
- 2017-10-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Risdiplam | Small molecule | 2 mg | Oral |
| Subject | Risdiplam | Small molecule | 6 mg | Oral |
| Subject | Risdiplam | Small molecule | 12 mg | Oral |
Indications
No indication recorded.